Skip to main content
Erschienen in: Digestive Diseases and Sciences 9/2017

01.06.2017 | Original Article

High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation

verfasst von: Eliza W. Beal, Sylvester M. Black, Khalid Mumtaz, Don Hayes Jr., Ashraf EL-Hinnawi, Kenneth Washburn, Dmitry Tumin

Erschienen in: Digestive Diseases and Sciences | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

High-risk donor allografts increase access to liver transplant, but potentially reduce patient and graft survival.

Aims

It is unclear whether the risk associated with using marginal donor livers is mitigated by increasing center experience.

Methods

The United Network for Organ Sharing registry was queried for adult first-time liver transplant recipients between 2/2002 and 12/2015. High donor risk was defined as donor risk index >1.9, and 1-year patient and graft survival were compared according to donor risk index in small and large centers. Multivariable Cox regression estimated the hazard ratio (HR) associated with using high-risk donor organs, according to a continuous measure of annual center volume.

Results

The analysis included 51,770 patients. In 67 small and 67 large centers, high donor risk index predicted increased mortality (p = 0.001). In multivariable analysis, high-donor risk index allografts predicted greater mortality hazard at centers performing 20 liver transplants per year (HR 1.35; 95% CI 1.22, 1.49; p < 0.001) and, similarly, at centers performing 70 per year (HR 1.35; 95% CI 1.26, 1.43; p < 0.001). The interaction between high donor risk index and center volume was not statistically significant (p = 0.747), confirming that the risk associated with using marginal donor livers was comparable between smaller and larger centers. Results were consistent when examining graft loss.

Conclusion

At both small and large centers, high-risk donor allografts were associated with reduced patient and graft survival after liver transplant. Specific strategies to mitigate the risk of liver transplant involving high-risk donors are needed, in addition to accumulation of center expertise.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134:1764–1776.CrossRefPubMed O’Leary JG, Lepe R, Davis GL. Indications for liver transplantation. Gastroenterology. 2008;134:1764–1776.CrossRefPubMed
2.
Zurück zum Zitat Adcock L, Macleod C, Dubay D, et al. Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience. Am J Transpl. 2010;10:364–371.CrossRef Adcock L, Macleod C, Dubay D, et al. Adult living liver donors have excellent long-term medical outcomes: the University of Toronto liver transplant experience. Am J Transpl. 2010;10:364–371.CrossRef
3.
Zurück zum Zitat Selzner M, Goldaracena N, Echeverri J, et al. Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: first North American results. Liver Transpl. 2016;22:1501–1508.CrossRefPubMed Selzner M, Goldaracena N, Echeverri J, et al. Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: first North American results. Liver Transpl. 2016;22:1501–1508.CrossRefPubMed
4.
Zurück zum Zitat Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation. 2006;82:1653–1657.CrossRefPubMed Maluf DG, Edwards EB, Kauffman HM. Utilization of extended donor criteria liver allograft: is the elevated risk of failure independent of the model for end-stage liver disease score of the recipient? Transplantation. 2006;82:1653–1657.CrossRefPubMed
5.
Zurück zum Zitat Nemes B, Gámán G, Polak WG, et al. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert Rev Gastroenterol Hepatol. 2016;10:841–859.CrossRefPubMed Nemes B, Gámán G, Polak WG, et al. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Expert Rev Gastroenterol Hepatol. 2016;10:841–859.CrossRefPubMed
6.
Zurück zum Zitat Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl. 2006;6:783–790.CrossRef Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transpl. 2006;6:783–790.CrossRef
7.
Zurück zum Zitat Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transpl. 2007;7:990–997.CrossRef Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transpl. 2007;7:990–997.CrossRef
8.
Zurück zum Zitat Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl. 2009;15:592–599.CrossRefPubMed Maluf DG, Edwards EB, Stravitz RT, Kauffman HM. Impact of the donor risk index on the outcome of hepatitis C virus-positive liver transplant recipients. Liver Transpl. 2009;15:592–599.CrossRefPubMed
9.
Zurück zum Zitat Bonney GK, Aldersley MA, Asthana S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation. 2009;87:1858–1863.CrossRefPubMed Bonney GK, Aldersley MA, Asthana S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation. 2009;87:1858–1863.CrossRefPubMed
10.
Zurück zum Zitat Alhamad T, Malone AF, Brennan DC, Stratta RJ, Chang SH, Wellen JR, et al. Transplant center volume and the risk of pancreas allograft failure. Transplantation. 2017. doi:10.1097/TP.0000000000001628. Alhamad T, Malone AF, Brennan DC, Stratta RJ, Chang SH, Wellen JR, et al. Transplant center volume and the risk of pancreas allograft failure. Transplantation. 2017. doi:10.​1097/​TP.​0000000000001628​.
11.
Zurück zum Zitat Kopp W, van Meel M, Putter H, Samuel U, Arbogast H, Schareck W, et al. Center Volume is associated with outcome after pancreas transplantation within the Eurotransplant region. Transplantation. 2017;101(6):1247–1253.CrossRefPubMed Kopp W, van Meel M, Putter H, Samuel U, Arbogast H, Schareck W, et al. Center Volume is associated with outcome after pancreas transplantation within the Eurotransplant region. Transplantation. 2017;101(6):1247–1253.CrossRefPubMed
12.
Zurück zum Zitat Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transpl. 2004;4:920–927.CrossRef Axelrod DA, Guidinger MK, McCullough KP, Leichtman AB, Punch JD, Merion RM. Association of center volume with outcome after liver and kidney transplantation. Am J Transpl. 2004;4:920–927.CrossRef
13.
Zurück zum Zitat Kilic A, George TJ, Beaty CA, Merlo CA, Conte JV, Shah AS. The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation. J Thorac Cardiovasc Surg. 2012;144:1502–1508. (discussion 8–9).CrossRefPubMed Kilic A, George TJ, Beaty CA, Merlo CA, Conte JV, Shah AS. The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation. J Thorac Cardiovasc Surg. 2012;144:1502–1508. (discussion 8–9).CrossRefPubMed
14.
Zurück zum Zitat Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV, et al. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg. 2012;143:157–167, 67.e1. Arnaoutakis GJ, George TJ, Allen JG, Russell SD, Shah AS, Conte JV, et al. Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant. J Thorac Cardiovasc Surg. 2012;143:157–167, 67.e1.
15.
Zurück zum Zitat Thabut G, Christie JD, Kremers WK, Fournier M, Halpern SD. Survival differences following lung transplantation among US transplant centers. JAMA. 2010;304:53–60.CrossRefPubMed Thabut G, Christie JD, Kremers WK, Fournier M, Halpern SD. Survival differences following lung transplantation among US transplant centers. JAMA. 2010;304:53–60.CrossRefPubMed
16.
Zurück zum Zitat Weiss ES, Allen JG, Meguid RA, et al. The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg. 2009;88:1062–1070.CrossRefPubMed Weiss ES, Allen JG, Meguid RA, et al. The impact of center volume on survival in lung transplantation: an analysis of more than 10,000 cases. Ann Thorac Surg. 2009;88:1062–1070.CrossRefPubMed
17.
18.
Zurück zum Zitat Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364–1369.CrossRefPubMed Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301:1364–1369.CrossRefPubMed
19.
Zurück zum Zitat Abecassis M, Bridges ND, Clancy CJ, et al. Solid-organ transplantation in older adults: current status and future research. Am J Transpl. 2012;12:2608–2622.CrossRef Abecassis M, Bridges ND, Clancy CJ, et al. Solid-organ transplantation in older adults: current status and future research. Am J Transpl. 2012;12:2608–2622.CrossRef
22.
Zurück zum Zitat Hayes D, Hartwig MG, Tobias JD, Tumin D. Lung transplant center volume ameliorates adverse influence of prolonged ischemic time on mortality. Am J Transpl. 2017;17:218–226.CrossRef Hayes D, Hartwig MG, Tobias JD, Tumin D. Lung transplant center volume ameliorates adverse influence of prolonged ischemic time on mortality. Am J Transpl. 2017;17:218–226.CrossRef
23.
Zurück zum Zitat Ozhathil DK, Li Y, Smith JK, et al. Effect of centre volume and high donor risk index on liver allograft survival. HPB (Oxford). 2011;13:447–453.CrossRef Ozhathil DK, Li Y, Smith JK, et al. Effect of centre volume and high donor risk index on liver allograft survival. HPB (Oxford). 2011;13:447–453.CrossRef
24.
Zurück zum Zitat Ozhathil DK, Li YF, Smith JK, et al. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl. 2011;17:1191–1199.CrossRefPubMed Ozhathil DK, Li YF, Smith JK, et al. Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl. 2011;17:1191–1199.CrossRefPubMed
25.
Zurück zum Zitat Attia M, Silva MA, Mirza DF. The marginal liver donor–an update. Transpl Int. 2008;21:713–724.CrossRefPubMed Attia M, Silva MA, Mirza DF. The marginal liver donor–an update. Transpl Int. 2008;21:713–724.CrossRefPubMed
26.
Zurück zum Zitat Sahni NR, Dalton M, Cutler DM, Birkmeyer JD, Chandra A. Surgeon specialization and operative mortality in United States: retrospective analysis. BMJ. 2016;354:i3571.CrossRefPubMedPubMedCentral Sahni NR, Dalton M, Cutler DM, Birkmeyer JD, Chandra A. Surgeon specialization and operative mortality in United States: retrospective analysis. BMJ. 2016;354:i3571.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Hayes D, Sweet SC, Benden C, Kopp BT, Goldfarb SB, Visner GA, et al. Transplant center volume and outcomes in lung transplantation for cystic fibrosis. Transpl Int. 2017;30(4):371–377.CrossRefPubMed Hayes D, Sweet SC, Benden C, Kopp BT, Goldfarb SB, Visner GA, et al. Transplant center volume and outcomes in lung transplantation for cystic fibrosis. Transpl Int. 2017;30(4):371–377.CrossRefPubMed
28.
Zurück zum Zitat Whitson BA, Black SM. Organ assessment and repair centers: the future of transplantation is near. World J Transpl. 2014;4:40–42. Whitson BA, Black SM. Organ assessment and repair centers: the future of transplantation is near. World J Transpl. 2014;4:40–42.
29.
Zurück zum Zitat Hayanga JA, Lira A, Vlahu T, et al. Procedural volume and survival after lung transplantation in the United States: the need to look beyond volume in the establishment of quality metrics. Am J Surg. 2016;211:671–676.CrossRefPubMed Hayanga JA, Lira A, Vlahu T, et al. Procedural volume and survival after lung transplantation in the United States: the need to look beyond volume in the establishment of quality metrics. Am J Surg. 2016;211:671–676.CrossRefPubMed
30.
Zurück zum Zitat Braat AE, Blok JJ, Putter H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transpl. 2012;12:2789–2796.CrossRef Braat AE, Blok JJ, Putter H, et al. The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transpl. 2012;12:2789–2796.CrossRef
31.
Zurück zum Zitat Blok JJ, Braat AE, Adam R, et al. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl. 2012;18:112–119.CrossRefPubMed Blok JJ, Braat AE, Adam R, et al. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl. 2012;18:112–119.CrossRefPubMed
32.
Zurück zum Zitat Collett D, Friend PJ, Watson CJ. Factors associated with short and long term liver graft survival in the United Kingdom: development of a UK donor liver index. Transplantation. 2017;101(4):786–792.CrossRefPubMed Collett D, Friend PJ, Watson CJ. Factors associated with short and long term liver graft survival in the United Kingdom: development of a UK donor liver index. Transplantation. 2017;101(4):786–792.CrossRefPubMed
33.
Zurück zum Zitat Jesudian A, Desale S, Julia J, et al. Donor factors including donor risk index predict fibrosis progression, allograft loss, and patient survival following liver transplantation for hepatitis c virus. J Clin Exp Hepatol. 2016;6:109–114.CrossRefPubMed Jesudian A, Desale S, Julia J, et al. Donor factors including donor risk index predict fibrosis progression, allograft loss, and patient survival following liver transplantation for hepatitis c virus. J Clin Exp Hepatol. 2016;6:109–114.CrossRefPubMed
34.
Zurück zum Zitat Aranzana EM, Coppini AZ, Ribeiro MA, Massarollo PC, Szutan LA, Ferreira FG. Model for end-stage liver disease, model for liver transplantation survival and donor risk index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo). 2015;70:413–418. doi:10.6061/clinics/2015(06)05. Epub Jun 1 2015.CrossRef Aranzana EM, Coppini AZ, Ribeiro MA, Massarollo PC, Szutan LA, Ferreira FG. Model for end-stage liver disease, model for liver transplantation survival and donor risk index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo). 2015;70:413–418. doi:10.​6061/​clinics/​2015(06)05. Epub Jun 1 2015.CrossRef
Metadaten
Titel
High Center Volume Does Not Mitigate Risk Associated with Using High Donor Risk Organs in Liver Transplantation
verfasst von
Eliza W. Beal
Sylvester M. Black
Khalid Mumtaz
Don Hayes Jr.
Ashraf EL-Hinnawi
Kenneth Washburn
Dmitry Tumin
Publikationsdatum
01.06.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 9/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4639-2

Weitere Artikel der Ausgabe 9/2017

Digestive Diseases and Sciences 9/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.